Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2012; 18(40): 5679-5687
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5679
Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5679
Table 3 Randomized trials of preoperative chemotherapy and radiation vs surgery alone
Ref. | Number of patients | Chemotherapy | Median survival (mo) | 3-yr survival (%) | ||
+CRT | -CRT | +CRT | -CRT | |||
Nygaard et al[14]1 | 103 | CDDP/bleomycin | 7 | 7 | 17 | 9 |
Le Prise et al[39] | 86 | CDDP/5-FU | 11 | 11 | 19 | 14 |
Apinop et al[40] | 69 | CDDP/5-FU | 9.7 | 7.4 | 26 | 20 |
Walsh et al[47]1 | 113 | CDDP/5-FU | 16 | 11 | 32 | 6 |
Bosset et al[38] | 282 | CDDP | 18.6 | 18.6 | 39 | 37 |
Urba et al[46] | 100 | CDDP/vinblastine/5-FU | 17.6 | 16.9 | 30 | 16 |
Burmeister et al[43] | 257 | CDDP/5-FU | 22 | 19 | - | - |
Lee et al[48] | 101 | CDDP/5-FU | 28.2 | 27.3 | - | - |
Tepper[45]1 | 56 | CDDP/5-FU | 53 | 21 | - | - |
van Hagen[41]1 | 386 | Carbo/paclitaxel | 49 | 24 | 58 | 44 |
- Citation: Almhanna K, Strosberg JR. Multimodality approach for locally advanced esophageal cancer. World J Gastroenterol 2012; 18(40): 5679-5687
- URL: https://www.wjgnet.com/1007-9327/full/v18/i40/5679.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i40.5679